Strata Critical Medical, Inc.
Financials
Valuation Metrics
Strata Critical Medical, Inc.'s Market Cap is $472M. At end of 2025 it was $397M. Ranked #2814 of 3,121 in US market (top 90%), #1236 of 1,463 on NASDAQ (top 84%), #90 of 93 in Transportation (top 97%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $472M | US#2,814/3,121 Sec#90/93 |
| Net Income | $40M | US#1,961/3,121 Sec#68/93 |
| Total Assets | $333M | US#2,891/3,121 Sec#93/93 |
| Net Assets | $279M | US#2,560/3,121 Sec#85/93 |
| Employees | 327 | US#2,397/3,121 Sec#77/93 |
| Value | ||
| P/E | 11.75x | US#502/3,121 Sec#22/93 |
| P/B | 1.69x | US#1,042/3,121 Sec#30/93 |
| P/S | 2.40x | US#1,470/3,121 Sec#64/93 |
| FCF Yield | -9.25% | US—/3,121 Sec—/93 |
| Profitability | ||
| ROE | 14.40% | US#937/3,121 Sec#38/93 |
| ROA | 12.09% | US#341/3,121 Sec#10/93 |
| Financial Health | ||
| Debt Ratio | 19.11% | US#215/3,121 Sec#3/93 |
| Total Debt | $4M | US#2,920/3,121 Sec#92/93 |
| FCF | $-44M | US#2,511/3,121 Sec#68/93 |
| Cash | $16M | US#2,903/3,121 Sec#87/93 |
| Current Ratio | 2.64x | US#922/3,121 Sec#16/93 |
| Performance | ||
| 1Y Return | -8.40% | US#1,693/3,121 Sec#68/93 |
| 1M Return | -9.34% | US#1,828/3,121 Sec#53/93 |
| From 52W High | -17.85% | US#1,299/3,121 Sec#40/93 |
| 1Y MDD | -32.21% | US#1,572/3,121 Sec#65/93 |
| Trading | ||
| Volume | 659,949 shares | US#1,919/3,121 Sec#51/93 |
| Trading Value | $4M | US#2,812/3,121 Sec#87/93 |
| Per Share | ||
| EPS | $0.45 | US#1,905/3,121 Sec#66/93 |
| BPS | $3.16 | US#2,476/3,121 Sec#81/93 |
Company Info
Strata Critical Medical, Inc. is dedicated to supporting healthcare providers throughout the United States by offering swift logistical management and specialized medical assistance. A significant part of their operations involves the movement of human organs for transplant, utilizing both aerial and ground transportation methods. Founded in 2014, the organization previously operated under the name Blade Air Mobility, Inc. and is set to officially change its name to Strata Critical Medical, Inc. in August of 2025. Its primary corporate office is located in New York, New York.